Zenas B. Noon
Directeur Général chez Pharos Pharmaceuticals, Inc.
Postes actifs de Zenas B. Noon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Pharos Pharmaceuticals, Inc. | Directeur Général | 01/01/1997 | - |
| Président | 01/01/1997 | - |
Historique de carrière de Zenas B. Noon
Anciens postes connus de Zenas B. Noon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENHANCE SKIN PRODUCTS, INC. | Directeur/Membre du Conseil | 30/08/2008 | 22/01/2014 |
| Independent Dir/Board Member | 08/09/2011 | 22/01/2014 | |
Cytologics, Inc.
 Cytologics, Inc. Pharmaceuticals: MajorHealth Technology Cytologics, Inc. manufactures pharmaceutical products. The company was founded in 1979 and is headquartered in Rochester, NY. | Président | 01/01/2000 | - |
| Independent Dir/Board Member | 01/01/2000 | - |
Formation de Zenas B. Noon
| University of Arizona | Graduate Degree |
| University of Illinois | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Independent Dir/Board Member | 2 |
| Chairman | 2 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 3 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Enhance Skin Products, Inc.
 Enhance Skin Products, Inc. Household/Personal CareConsumer Non-Durables Enhance Skin Products, Inc. develops and markets cosmeceuticals. It offers a skin care line under its Visible Youth trademark which includes products such as topical treatment, eye zone gel, moisturizer, cleanser and healing complex formula. The company was founded on November 14, 2006 and is headquartered in Reno, NV. | Consumer Non-Durables |
| Pharos Pharmaceuticals, Inc. | |
Cytologics, Inc.
Cytologics, Inc. Pharmaceuticals: MajorHealth Technology Cytologics, Inc. manufactures pharmaceutical products. The company was founded in 1979 and is headquartered in Rochester, NY. | Health Technology |
- Bourse
- Insiders
- Zenas B. Noon
- Expérience
